Elusys Therapeutics INC
UEI ELP1DCK8L191 CAGE 1WEK8 Active Parsippany, NJ
Other Than Small Business · Data through July 7, 2026
Obligations by fiscal year
| Fiscal year | Obligations |
|---|---|
| FY2026 | -$100K |
| FY2025 | $55.3M |
| FY2024 | $68.4M |
| FY2023 | -$831K |
| FY2022 | $31.0M |
| FY2021 | $50.0M |
Agencies, NAICS, and PSC codes
| Agency | Obligations | Share |
|---|---|---|
| Department of Health and Human Services | $203.8M | 100% |
| NAICS code | Obligations | Share |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $203.7M | 99.9% |
| 541711 — Research and Development in Biotechnology | $131K | 0.1% |
| PSC code | Obligations | Share |
|---|---|---|
| 6505 — Drugs and Biologicals | $204.5M | 100.3% |
| C118 — Research and Development Facilities | $630K | 0.3% |
| AN13 — Health R&D Services; Health Care Services; Experimental Development | -$1.3M | -0.6% |
Contract type and set-aside mix
| Contract pricing type | Obligations | Share |
|---|---|---|
| Firm Fixed Price | $203.7M | 99.9% |
| Cost Plus Fixed Fee | $131K | 0.1% |
| Set-aside type | Obligations | Share |
|---|---|---|
| No Set Aside Used. | $204.6M | 100.4% |
| Small Business Set Aside - Partial | -$100K | 0% |
| Not Specified | -$702K | -0.3% |
Place of performance by state
| State | Obligations | Share |
|---|---|---|
| NJ | $203.3M | 99.7% |
| Not specified | $530K | 0.3% |
Largest contract actions on file
| Award | Agency | Period of performance | Obligation | Record |
|---|---|---|---|---|
| 75A50324C00006 · NAICS 325412 | Department of Health and Human Services | May 1, 2024 – April 30, 2027 | $69.3M | View on USAspending |
| 75A50324C00006 · NAICS 325412 | Department of Health and Human Services | May 1, 2024 – December 31, 2028 | $55.3M | View on USAspending |
| 75A50324C00006 · NAICS 325412 | Department of Health and Human Services | May 1, 2024 – April 30, 2027 | $55.1M | View on USAspending |
| 75A50121C00073 · NAICS 325412 | Department of Health and Human Services | August 6, 2021 – October 31, 2021 | $50.0M | View on USAspending |
| 75A50121C00073 · NAICS 325412 | Department of Health and Human Services | August 6, 2021 – April 15, 2023 | $30.9M | View on USAspending |
| 75A50324C00006 · NAICS 325412 | Department of Health and Human Services | May 1, 2024 – December 31, 2028 | $9.6M | View on USAspending |
| HHSO100201100034C · NAICS 541711 | Department of Health and Human Services | September 15, 2011 – — | $912K | View on USAspending |
| HHSO10033001T · NAICS 325412 | Department of Health and Human Services | November 2, 2015 – September 30, 2021 | $31K | View on USAspending |
| 75A50118F33002 · NAICS 325412 | Department of Health and Human Services | April 16, 2018 – November 30, 2021 | $0 | View on USAspending |
| 75A50118F33002 · NAICS 325412 | Department of Health and Human Services | April 16, 2018 – April 14, 2023 | $0 | View on USAspending |
Parent company
Nighthawk Biosciences, INC. (UEI HQUBBMC377D4)
Similar contractors
- Partner Therapeutics, INC. — $207.3M, Lexington, MA
- Teva Pharmaceuticals Usa, INC. — $222.0M, Parsippany, NJ
- Exelan Pharmaceuticals INC — $179.3M, Boca Raton, FL
- Genentech Usa, INC — $168.7M, South San Francisco, CA
- Fresenius Kabi, LLC — $164.7M, Lake Zurich, IL
- Meridian Medical Technologies, LLC — $161.4M, Columbia, MD
- Cardinal Health 414, LLC — $156.9M, Dublin, OH
- Progenics Pharmaceuticals INC — $146.5M, North Billerica, MA
What the numbers show
100% of this contractor's obligations on file ($203.8M of $203.8M) came from a single agency, Department of Health and Human Services.
No transaction in this record used a small-business set-aside; all obligations were awarded with no set-aside or an unspecified type.
Net obligations for FY2026 were negative (-$100K): de-obligations on existing contracts exceeded new obligations that fiscal year.
Obligations decreased from $55.3M in FY2025 to -$100K in FY2026, the last closed fiscal year.
Source: USAspending.gov, U.S. Department of the Treasury. Contract transactions FY2021–FY2026, downloaded 2026-10-21. Figures are net obligations and can include de-obligations. Department of Defense data is published with a 90-day delay. View this contractor's largest contract on USAspending.gov.
To request removal of this profile, use the contact form and select "Removal request." Requests are processed within 30 days.